Non-resectable colorectal liver metastases treated with cetuximab induction toward liver R0 resection trial

Trial Profile

Non-resectable colorectal liver metastases treated with cetuximab induction toward liver R0 resection trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Cancer metastases; Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms NEXTO
  • Most Recent Events

    • 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 11 Oct 2016 Results (n=50) assessing efficacy and safety presented at the 41st European Society for Medical Oncology Congress.
    • 16 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top